Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Surgery, Gynecology & Obstetrics
|
December 1, 1975
Melphalan versus adriamycin in the treatment of advanced carcinoma of the ovary
G M de Palo, M de Lena, F Di Re, et al.
La Radiologia Medica
|
January 1, 1983
[Comparison of radiotherapy and surgery in the management of cervical cancer in stages Ib and II]
F Volterrani, L Feltre, M Di Giuseppe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1993
High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancer
F Di Re, S Bohm, S Oriana, et al.
Cancer Treatment Reviews
|
September 1, 1990
Glutathione and detoxification
M Tedeschi, S Bohm, F Di Re, et al.
American Journal of Clinical Oncology
|
June 1, 1990
Cisplatin and cyclophosphamide in advanced ovarian carcinoma: activity and toxicity of an ambulatory regimen
M Zambetti, L Gianni, F Di Re, et al.
AJR. American Journal of Roentgenology
|
March 1, 1980
Retroperitoneal metastases from ovarian carcinoma: reassessment of 365 patients studied with lymphography
R Musumeci, G De Palo, R Kenda, et al.
Anticancer Research
|
July 1, 1991
A feasibility study of cisplatin administration with low-volume hydration and glutathione protection in the treatment of ovarian carcinoma
S Bohm, G Battista Spatti, F Di Re, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology
|
January 1, 1989
Evaluation of the suitability of a monoclonal antibody raised against human ovarian carcinoma for therapeutic approaches
M I Colnaghi, G L Buraggi, S Canevari, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 1, 1987
Germ cell tumors of the ovary: the experience of the National Cancer Institute of Milan. I. Dysgerminoma
G De Palo, A Lattuada, R Kenda, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Mitoxantrone and ifosfamide as second-line therapy of epithelial ovarian cancer. A pilot study by the I.T.M.O. Group
A Di Leo, E Bajetta, L Biganzoli, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Surgery, Gynecology & Obstetrics
|
December 1, 1975
Melphalan versus adriamycin in the treatment of advanced carcinoma of the ovary
G M de Palo, M de Lena, F Di Re, et al.
La Radiologia Medica
|
January 1, 1983
[Comparison of radiotherapy and surgery in the management of cervical cancer in stages Ib and II]
F Volterrani, L Feltre, M Di Giuseppe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1993
High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancer
F Di Re, S Bohm, S Oriana, et al.
Cancer Treatment Reviews
|
September 1, 1990
Glutathione and detoxification
M Tedeschi, S Bohm, F Di Re, et al.
American Journal of Clinical Oncology
|
June 1, 1990
Cisplatin and cyclophosphamide in advanced ovarian carcinoma: activity and toxicity of an ambulatory regimen
M Zambetti, L Gianni, F Di Re, et al.
AJR. American Journal of Roentgenology
|
March 1, 1980
Retroperitoneal metastases from ovarian carcinoma: reassessment of 365 patients studied with lymphography
R Musumeci, G De Palo, R Kenda, et al.
Anticancer Research
|
July 1, 1991
A feasibility study of cisplatin administration with low-volume hydration and glutathione protection in the treatment of ovarian carcinoma
S Bohm, G Battista Spatti, F Di Re, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology
|
January 1, 1989
Evaluation of the suitability of a monoclonal antibody raised against human ovarian carcinoma for therapeutic approaches
M I Colnaghi, G L Buraggi, S Canevari, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 1, 1987
Germ cell tumors of the ovary: the experience of the National Cancer Institute of Milan. I. Dysgerminoma
G De Palo, A Lattuada, R Kenda, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Mitoxantrone and ifosfamide as second-line therapy of epithelial ovarian cancer. A pilot study by the I.T.M.O. Group
A Di Leo, E Bajetta, L Biganzoli, et al.
Page
of 4